SynthesisFrontiers in public health2025
Modifiable lifestyle and metabolic risk factors for colorectal polyps: a systematic review and meta-analysis.
Synthesis in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- HDL-C presents a suggestive negative moderating trend for the association between total cholesterol and colorectal polyps: model construction and bootstrap internal assessment of a predictive nomogram.Frontiers in endocrinology · 2026Article
- Navigating the Terrain of Post-Polypectomy Surveillance: Charting the Complex Landscape of Guidelines and Recurrence Risks.Canadian journal of gastroenterology & hepatology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate associations between unhealthy lifestyles, metabolic diseases, and colorectal polyps, with emphasis on subtype-specific effects. Methods: We systematically searched PubMed, Embase, Cochrane Library, and SinoMed (up to July 2024) for studies reporting odds ratios (ORs) of colorectal polyps associated with lifestyle or metabolic factors. Heterogeneity was quantified using I (2) statistics, with random-effects models applied as the primary analytical approach. Subgroup analyses were conducted to investigate potential effect modifiers, and meta-regression was performed to explore continuous sources of heterogeneity, while sensitivity analyses and funnel plots evaluated robustness and bias. Results: Alcohol (OR = 1.63, 95%CI:1.48-1.78), high-fat diet (OR = 1.45, 95%CI:1.33-1.57), and smoking (OR = 1.79, 95%CI:1.69-1.90) significantly increased polyp risk across subtypes. Smoking showed subtype- and region-specific effects, with the highest risk for sessile serrated lesions (SSLs; (OR = 3.06, 95%CI:2.41-3.90)) and in the US, South Korea, and Israel. Type 2 diabetes had the strongest metabolic association (OR = 2.17,95%CI:1.82- 2.60), followed by hyperlipidemia (OR = 1.50, 95%CI:1.32-1.70) and hypertension (OR = 1.33, 95%CI:1.10-1.61). Heterogeneity stemmed from pathological classification and geographic variation, with no significant publication bias. Conclusion: Unhealthy lifestyles (alcohol, high-fat diet, smoking) and metabolic diseases (type 2 diabetes, hyperlipidemia, hypertension) independently increase colorectal polyp risk, with smoking demonstrating pronounced subtype and regional variability. These findings can inform the development of risk-stratified screening protocols and targeted public health interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.